Technological substitution risk if thermoplastic composites gain adoption over thermoset systems (Hexcel's core technology), though transition timeline likely 10+ years given aircraft certification requirements
Concentration risk with Boeing and Airbus representing ~55% of revenue - production delays, program cancellations, or insourcing decisions create significant exposure
Geopolitical supply chain risks as 30% of revenue comes from European operations and China represents growing but uncertain commercial aerospace market
Toray Industries and Teijin expanding carbon fiber capacity in Asia with 20-30% lower cost structures, though qualification barriers protect existing programs
Vertical integration by OEMs - Boeing and Airbus periodically evaluate bringing composite manufacturing in-house to capture margins, particularly on next-generation aircraft programs
Private equity-backed competitors (Cytec acquired by Solvay) pursuing aggressive pricing on new program wins to gain share
Debt/EBITDA ratio of ~3.0x is elevated for cyclical industrial, limiting financial flexibility if aerospace downturn extends beyond current expectations
Pension obligations of $180M (underfunded status) could require incremental cash contributions if discount rates decline or asset returns disappoint
Working capital intensity - inventory levels of $550M+ require careful management during production rate changes to avoid cash flow volatility
StructuralCompetitiveBalance Sheet